The relevance of EVs in the response to immunotherapy with anti-PD-L1 in SCLC was explored by Duo and co-authors, who hypothesized that SCLC cells generate EVs which may be mediators of tumor progression and immunosuppression. This evidence concerns the gene CD274 and neoplasm.